Enspryng Interactions
There are 354 drugs known to interact with Enspryng (satralizumab), along with 3 disease interactions. Of the total drug interactions, 60 are major, 286 are moderate, and 8 are minor.
- View all 354 medications that may interact with Enspryng
- View Enspryng disease interactions (3)
Most frequently checked interactions
View interaction reports for Enspryng (satralizumab) and the medicines listed below.
- acetaminophen
- acetaminophen / hydrocodone
- Acidophilus (lactobacillus acidophilus)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Adderall XR (amphetamine / dextroamphetamine)
- Advate (antihemophilic factor)
- Afinitor (everolimus)
- Afrin (oxymetazoline nasal)
- Afstyla (antihemophilic factor)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- AK-Sulf (sulfacetamide sodium ophthalmic)
- Aleve (naproxen)
- Allegra (fexofenadine)
- aloe vera
- alprazolam
- aluminum hydroxide / magnesium trisilicate
- amoxapine
- amoxicillin
- amoxicillin / clavulanate
- carbamazepine
- Celebrex (celecoxib)
- duloxetine
- gabapentin
- Metamucil (psyllium)
- methylphenidate
- metoprolol
- prednisone
- pregabalin
- tramadol
Enspryng disease interactions
There are 3 disease interactions with Enspryng (satralizumab) which include:
More about Enspryng (satralizumab)
- Enspryng consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Uplizna
Uplizna is used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) or ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Bkemv
Bkemv (eculizumab-aeeb) is an interchangeable biosimilar to Soliris which may be used to treat ...
Epysqli
Epysqli (eculizumab-aagh), a biosimilar to Soliris, targets the complement system to treat ...
Inebilizumab
Inebilizumab is used to treat adults with NMOSD (neuromyelitis optica spectrum disorder) who are ...
Ravulizumab
Ravulizumab-cwvz is used to treat myasthenia gravis (gMG), hemolytic uremic syndrome (aHUS) ...
Eculizumab
Eculizumab (brand names Soliris, Bkemv, and Epysqli) is used to treat paroxysmal nocturnal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.